Amifostine 200 mg/m2 three times weekly vs Amifostine 200 mg/m2 five times weekly
Survival (overall survival and locoregional control) · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head and neck region
1 finding from 1 review
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomesInsufficient evidence reported on overall survival or locoregional tumour control (Analysis 4.2; 4.3)1 studyGRADE not reported